abstract |
Use for the vasculopathy treatment of compounds or salts thereof, having the following general formula: A-(B) b0 -(C) c0 -NO 2 wherein A is the radical of the precursor drug selected between the salicylic or acetylsalicylic acid, B and C are bivalent linking groups as defined in the invention. |